Skip to main content
. Author manuscript; available in PMC: 2019 Feb 6.
Published in final edited form as: Ann Neurol. 2018 Feb 6;83(2):269–282. doi: 10.1002/ana.25144

Table 1.

Clinical and genetic information on subjects.

Patient ID Mutations Age Patient ID Disease Clinical
Severity
References
Control (CTRL)
CTRL - 1 N/A 21 yrs - - - 51
CTRL - 2 N/A 31 yrs - - - 51
CTRL - 3 N/A 54 yrs - - - 51
CTRL - 4 N/A 39 yrs - - - 51
CTRL - 5 N/A 53 yrs - - - U
CTRL - 6 N/A 51 yrs - - - U
CTRL - 7 N/A 51 yrs - - - U
Skeletal muscle alpha-actin patients (NEM3)
NEM3 – P1 p. Gly57Arg 7 mo BOS922-1 | T866 NM Typical 19
NEM3 – P2 p. Arg258His 2 mo BOS927-1 | T865 NM Typical 19
NEM3 – P3 p. Thr79Ala 10 mo BOS95-1 | T77 NM Typical 57
NEM3 – P4 p. Glu85Lys 2.8 yrs BOS349-1 | T256 NM Typical 57
NEM3 – P5 p. Ala274Gly 3 yrs - NM Typical 57
NEM3 – P6 p. Ala206Thr 60 yrs - NM Mild 4
NEM3 – P7 p. Gly270Cys 4 yrs - NM Chilhood onset 58
NEM3 – P8 p. Val165Met 65 yrs - NM Mild 59
NEM3 – P9 p. Asn117Ser 17 yrs - NM Chilhood onset 58
NEM3 – P10 p. Asp186His 1 mo - NM Severe 2
NEM3 – P11 p. Arg198Cys 5 yrs - NM Severe U
NEM3 – P12 p. Ile138Met 23 yrs - NM Typical 60
NEM3 – P13 p. Glu119Gln 1 yr - NM Severe U
NEM3 – P14 p. Arg185Cys 41 yrs - NM Mild 61

U: unpublished